A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B

NCT06150014 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: Placebo
DRUG: TQA3605 tablets
DRUG: Entecavir dispersible tablets
DRUG: Tenofovir disoproxil fumarate tablet
DRUG: Tenofovir alafenamide fumarate tablet

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.